In most cases, angiogenesis is enhanced by upregulating endogenous vascular endothelial growth factor (VEGF) and other angiogenic signaling pathways in endothelial cells, which are ascribed to the pro-angiogenic effects of tumor-derived EVs. The gene discussed is VEGFA; the disease is neoplasm.